National Research Corporation Reports Record Recurring Contract Value

Key Points:

• National Research Corporation (NRC) has announced a significant milestone, surpassing \$152 million in Total Recurring Contract Value (TRCV) as of March 4, 2026.
• This figure represents an all-time high for NRC, marking a new peak in recurring contract value in the company’s history.
• The announcement was made via a press release, which was furnished as an exhibit to NRC’s Form 8-K filed with the SEC.
• No amendment to prior filings; the report is current, not a revision of previous disclosures.

Details Investors Should Know

• Business Update: The increase to \$152 million in TRCV signals robust growth and strong ongoing client relationships, which may imply increasing revenue visibility and financial stability.
• Potential Share Price Impact:
  • The achievement of a new record in recurring contract value is typically viewed as a positive indicator for future financial performance. This could be price sensitive and may affect the company’s share value, especially as recurring revenue streams are highly valued in the market for their predictability and reduced risk.
  • As NRC’s common stock (\$.001 par value) trades under the symbol NRC on the NASDAQ Stock Market, this news may attract investor attention and potentially drive share price movement.
• Corporate Details:
  • NRC is incorporated in Delaware and headquartered at 1245 Q Street, Lincoln, NE 68508.
  • Executive Vice President and Chief Financial Officer, Shane Harrison, signed the filing.
• Regulatory Disclosure: The information was provided under Regulation FD Disclosure and Financial Statements and Exhibits in Form 8-K, indicating its relevance to shareholders and the investing public.
• Forward-Looking Statements:
  • The press release includes forward-looking statements regarding future dividends and other financial expectations. These statements are subject to risks and uncertainties, and actual results may differ materially.
  • Shareholders should note that NRC disclaims any obligation to update these forward-looking statements, and are advised to review risk factors in NRC’s annual report and SEC filings for more information.

Additional Information

• NRC is not an emerging growth company under SEC definitions, suggesting a more established status.
• No written communications, soliciting material, or pre-commencement communications relating to tender offers are reported in this filing.
• Securities registered with the SEC include NRC’s common stock, traded on NASDAQ.
• Contact information is provided for both media ([email protected]) and investors ([email protected]).

Conclusion: The announcement that NRC has reached a record \$152 million in Total Recurring Contract Value is a noteworthy development for shareholders and potential investors. This milestone underscores NRC’s growth trajectory and may positively influence share price, given its implications for future revenues and the company’s financial outlook.

Disclaimer: This article contains information based on NRC’s SEC filings and press releases, including forward-looking statements that are subject to risks and uncertainties. Actual results may differ. Investors should review NRC’s official filings and consult professional advisors before making investment decisions. This article does not constitute investment advice or an official communication from National Research Corporation.

View NATIONAL RESEARCH CORP Historical chart here